BioSpace News Archive

An oral presentation at the American Heart Association’s Scientific Sessions examined recent reporting rates of esophageal injury after left atrial ablation for the treatment of atrial fibrillation and found that the rates have not decreased in the last four years.

InGeneron, Inc., a clinical-stage biotechnology company, today announced positive clinical trial data demonstrating long-term safety and efficacy of InGeneron’s cell therapy for treating partial-thickness rotator cuff tears.

People with arthritis who report more negative feelings about how they are aging tend to get less physical activity and perceive themselves as less healthy, according to a new study by researchers at Hospital for Special Surgery and Weill Cornell Medicine.

Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today provided a corporate update and reported financial results for the third quarter ended September 30, 2023.

Avenue Therapeutics, Inc. reported financial results and recent corporate highlights for the third quarter ended September 30, 2023.

Ardelyx, Inc., a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, announced that Geoffrey Block, MD, is stepping down from the Board of Directors after nearly five years of service.

Cara Therapeutics, Inc. (Nasdaq: CARA), a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced financial results and operational highlights for the third quarter ended September 30, 2023.

Hepion Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on Artificial Intelligence -driven therapeutic drug development for the treatment of metabolic dysfunction-associated steatohepatitis, fibrotic diseases, hepatocellular carcinoma, and other chronic diseases, announced additional efficacy data for rencofilstat, its lead drug candidate.

Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI) announced today its strategic, operational and financial results for the quarter ended September 30, 2023.

Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, today reported financial results for the third quarter ended September 30, 2023 and provided recent business highlights.